Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
FLDM Fluidigm Corporation daily Stock Chart
FLDM [NASD]
Fluidigm Corporation
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E- EPS (ttm)-1.49 Insider Own1.00% Shs Outstand39.00M Perf Week-4.45%
Market Cap292.91M Forward P/E- EPS next Y-1.22 Insider Trans167.36% Shs Float38.67M Perf Month-8.41%
Income-55.90M PEG- EPS next Q-0.38 Inst Own93.34% Short Float11.53% Perf Quarter14.83%
Sales104.20M P/S2.81 EPS this Y29.90% Inst Trans0.11% Short Ratio25.10 Perf Half Y22.31%
Book/sh0.89 P/B8.44 EPS next Y15.90% ROA-20.20% Target Price7.65 Perf Year68.39%
Cash/sh1.04 P/C7.25 EPS next 5Y-8.06% ROE-145.70% 52W Range4.43 - 8.62 Perf YTD27.50%
Dividend- P/FCF- EPS past 5Y-16.40% ROI-24.40% 52W High-12.90% Beta2.89
Dividend %- Quick Ratio1.60 Sales past 5Y14.30% Gross Margin51.30% 52W Low69.53% ATR0.40
Employees505 Current Ratio2.10 Sales Q/Q10.50% Oper. Margin-47.90% RSI (14)46.49 Volatility5.85% 4.87%
OptionableYes Debt/Eq4.79 EPS Q/Q27.80% Profit Margin-53.70% Rel Volume1.58 Prev Close7.95
ShortableYes LT Debt/Eq4.79 EarningsNov 01 AMC Payout- Avg Volume177.63K Price7.51
Recom3.00 SMA20-2.53% SMA50-2.22% SMA20014.82% Volume280,728 Change-5.53%
Aug-05-16Reiterated Mizuho Buy $11 → $12
Aug-05-16Reiterated Cantor Fitzgerald Buy $13 → $11
May-05-16Reiterated Mizuho Buy $8 → $11
Apr-12-16Reiterated Leerink Partners Outperform $20 → $15
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
Feb-03-14Reiterated Oppenheimer Outperform $46 → $52
Jan-14-14Reiterated Mizuho Neutral $30 → $43
Dec-18-13Reiterated Maxim Group Buy $33 → $42
Oct-31-13Reiterated Mizuho Neutral $19 → $30
Oct-31-13Reiterated Maxim Group Buy $26 → $33
Oct-16-18 07:45AM  Market Trends Toward New Normal in Globant S.A, EZCORP, Earthstone Energy, SPX, Fluidigm, and MAG Silver Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-04-18 08:30AM  Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD GlobeNewswire
Oct-01-18 04:15PM  Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results GlobeNewswire
Sep-27-18 04:05PM  Fluidigm Introduces Single-Cell Total RNA Sequencing Applications for C1 GlobeNewswire
Sep-10-18 08:30AM  Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis GlobeNewswire
Sep-07-18 07:30AM  Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD GlobeNewswire
Sep-05-18 06:00PM  Fluidigm to Participate at Upcoming Investor Events in September GlobeNewswire
Aug-15-18 07:45AM  Detailed Research: Economic Perspectives on Middlesex Water, Farmer Brothers, Fluidigm, QCR, Revlon, and Gladstone Land What Drives Growth in Today's Competitive Landscape GlobeNewswire
Aug-09-18 08:30AM  Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting GlobeNewswire
Aug-06-18 04:05PM  Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-03-18 05:25PM  Edited Transcript of FLDM earnings conference call or presentation 2-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
09:25AM  Fluidigm (FLDM) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:05AM  Fluidigm: 2Q Earnings Snapshot Associated Press
Aug-02-18 04:05PM  Fluidigm Announces Second Quarter 2018 Financial Results GlobeNewswire
Jul-31-18 08:30AM  Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1 GlobeNewswire +5.96%
Jul-10-18 08:30AM  Fluidigm Announces First Multimodal Single-Cell Application for the C1 GlobeNewswire
Jul-05-18 04:05PM  Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results GlobeNewswire
Jun-29-18 10:59AM  Zacks.com featured highlights include: Hershey, Polaris, Lithia, Fluidigm and Univar Zacks
Jun-28-18 07:32AM  Bet on Rising P/E Investing With These 5 Top-Ranked Stocks Zacks
Jun-26-18 08:30AM  David King Joins Fluidigm as Vice President, Research and Development, Genomics GlobeNewswire
Jun-13-18 02:12PM  Edited Transcript of FLDM earnings conference call or presentation 3-May-18 9:00pm GMT Thomson Reuters StreetEvents
Jun-07-18 11:14AM  Fluidigm Corporations (NASDAQ:FLDM) Insiders Ramped Up Holdings Should You? Simply Wall St.
07:00AM  Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service GlobeNewswire
Jun-05-18 06:30AM  Fluidigm Releases Sample Identification Genotyping Panel for Translational and Clinical Research GlobeNewswire
May-11-18 07:10AM  Free Research Report as Thermo Fisher Scientifics Quarterly Revenue Surged 23%; Adjusted EPS Jumped 20% ACCESSWIRE
May-10-18 07:02PM  Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-09-18 04:05PM  Fluidigm to Participate in Upcoming Investor Events GlobeNewswire
May-03-18 06:14PM  Fluidigm: 1Q Earnings Snapshot Associated Press +5.61%
04:04PM  Fluidigm Announces First Quarter Financial Results and Operational Progress GlobeNewswire
Apr-30-18 07:45AM  Report: Developing Opportunities within Fluidigm, MaxLinear, Southern National Bancorp of Virginia, Power Integrations, Hersha Hospitality Trust, and W.R. Berkley Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-23-18 08:00AM  Brad Kreger Joins Fluidigm as Senior Vice President, Global Operations GlobeNewswire
Apr-19-18 08:42PM  Has Fluidigm Corporation (NASDAQ:FLDM) Improved Earnings Growth In Recent Times? Simply Wall St.
04:05PM  Fluidigm to Report Q1 2018 Financial Results and Host Conference Call GlobeNewswire
Apr-13-18 04:10PM  Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research GlobeNewswire
Apr-12-18 09:29AM  Fluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno System GlobeNewswire
Mar-19-18 07:50AM  Report: Exploring Fundamental Drivers Behind Fluidigm, Acuity Brands, TTEC, Actuant, Equity Lifestyle Properties, and Stemline Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Mar-13-18 08:54AM  What Investors Should Know About Fluidigm Corporations (NASDAQ:FLDM) Financial Strength Simply Wall St.
07:45AM  Fluidigm Announces Exchange of Convertible Notes GlobeNewswire
Mar-02-18 07:45AM  Fluidigm Announces Exchange of Convertible Notes GlobeNewswire -8.47%
Feb-27-18 05:03PM  What Should Investors Know About The Future Of Fluidigm Corporations (NASDAQ:FLDM) Business? Simply Wall St.
Feb-22-18 06:36PM  Edited Transcript of FLDM earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents -6.08%
Feb-15-18 07:30AM  Wired News Charles River Labs Inked an Agreement to Acquire MPI Research ACCESSWIRE +10.85%
Feb-14-18 04:05PM  Fluidigm to Participate in Upcoming Health Care Investor Conferences GlobeNewswire
07:20AM  Free Post Earnings Research Report: Thermo Fishers Quarterly Revenue Surged 22%; Adjusted EPS Advanced 16% ACCESSWIRE
Feb-08-18 09:07PM  Fluidigm reports 4Q loss Associated Press
04:05PM  Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress GlobeNewswire
12:50PM  Fluidigm Corporation to Host Earnings Call ACCESSWIRE
10:32AM  Is Fluidigm Corporation (NASDAQ:FLDM) Undervalued? Simply Wall St.
Jan-25-18 04:05PM  Fluidigm to Report Q4 and Full Year 2017 Financial Results GlobeNewswire
Jan-09-18 07:30AM  Detailed Research: Economic Perspectives on Fluidigm, Stemline Therapeutics, NeoGenomics, CVR Energy, W.R. Berkley, and Mack-Cali Realty What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-01-18 11:35AM  ETFs with exposure to Fluidigm Corp. : January 1, 2018 Capital Cube
Dec-29-17 05:55PM  Was Fluidigm Corporations (NASDAQ:FLDM) Earnings Growth Better Than Industry? Simply Wall St.
Dec-21-17 04:05PM  Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-19-17 01:01PM  ETFs with exposure to Fluidigm Corp. : December 19, 2017 Capital Cube
Dec-07-17 01:44PM  ETFs with exposure to Fluidigm Corp. : December 7, 2017 Capital Cube
Nov-27-17 01:37PM  ETFs with exposure to Fluidigm Corp. : November 27, 2017 Capital Cube +6.08%
Nov-24-17 11:34PM  Edited Transcript of FLDM earnings conference call or presentation 2-Nov-17 9:00pm GMT Thomson Reuters StreetEvents
Nov-21-17 09:06AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017 Capital Cube
Nov-14-17 04:05PM  Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire +5.38%
Nov-02-17 06:19PM  Fluidigm reports 3Q loss Associated Press
04:05PM  Fluidigm Announces Third Quarter Financial Results and Operational Progress GlobeNewswire
12:30PM  Fluidigm Corporation to Host Earnings Call ACCESSWIRE
Oct-31-17 08:25PM  Does Fluidigm Corporations (FLDM) Debt Level Pose A Serious Problem? Simply Wall St.
Oct-25-17 09:58AM  ETFs with exposure to Fluidigm Corp. : October 25, 2017 Capital Cube
Oct-24-17 08:10AM  Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis GlobeNewswire
08:00AM  Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues GlobeNewswire
Oct-19-17 04:05PM  Fluidigm to Report Q3 2017 Financial Results and Host Conference Call GlobeNewswire
Oct-18-17 09:00AM  Fluidigm to Unveil High-Parameter Tissue Imaging System GlobeNewswire
Oct-11-17 11:31AM  ETFs with exposure to Fluidigm Corp. : October 11, 2017 Capital Cube
Sep-30-17 03:37PM  Should You Be Concerned About Fluidigm Corporations (FLDM) Risks? Simply Wall St.
Aug-28-17 04:05PM  Fluidigm to Participate in Two Upcoming Health Care Conferences in September GlobeNewswire
Aug-25-17 04:26PM  ETFs with exposure to Fluidigm Corp. : August 25, 2017 Capital Cube +14.99%
Aug-18-17 07:47AM  Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics Zacks
Aug-17-17 04:05PM  Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System GlobeNewswire
Aug-16-17 11:09AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-11-17 06:50PM  Edited Transcript of FLDM earnings conference call or presentation 3-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-10-17 07:20PM  Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering GlobeNewswire +5.96%
Aug-05-17 01:10AM  Fluidigm reports 2Q loss Associated Press
Aug-03-17 04:05PM  Fluidigm Announces Second Quarter Financial Results and Operational Progress GlobeNewswire
02:30PM  Investor Network: Fluidigm Corporation to Host Earnings Call ACCESSWIRE
Aug-02-17 06:00AM  Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan GlobeNewswire -5.25%
Jul-27-17 04:05PM  Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China GlobeNewswire
Jul-20-17 04:05PM  Fluidigm to Report Q2 2017 Financial Results and Host Conference Call GlobeNewswire
Jul-18-17 09:00AM  Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research GlobeNewswire -8.10%
Jul-10-17 02:29PM  ETFs with exposure to Fluidigm Corp. : July 10, 2017 Capital Cube
Jun-16-17 03:47PM  ETFs with exposure to Fluidigm Corp. : June 16, 2017 Capital Cube
Jun-02-17 02:08PM  ETFs with exposure to Fluidigm Corp. : June 2, 2017 Capital Cube
May-23-17 08:50PM  Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents -10.35%
May-15-17 03:44PM  ETFs with exposure to Fluidigm Corp. : May 15, 2017 Capital Cube
May-12-17 10:37AM  Fluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
May-10-17 08:40PM  Edited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-05-17 05:02AM  Fluidigm reports 1Q loss Associated Press +17.53%
May-04-17 04:10PM  European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research GlobeNewswire
04:05PM  Fluidigm Announces First Quarter Financial Results GlobeNewswire
01:25PM  Investor Network: Fluidigm Corporation to Host Earnings Call Accesswire
Apr-28-17 06:54AM  Cerner (CERN) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-27-17 09:46AM  CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y Zacks
Apr-20-17 04:05PM  Fluidigm to Report Q1 2017 Financial Results and Host Conference Call GlobeNewswire
Apr-07-17 10:06AM  Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System Zacks
09:49AM  Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital Zacks
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell genomics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments and consumables, including IFCs, assays, and reagents to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 12Buy7.451813411,302,171Oct 15 06:05 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 11Buy7.445339411,302,153Oct 15 06:05 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 09Buy7.2934,896254,21711,302,100Oct 11 04:31 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorOct 01Buy7.562418111,267,204Oct 03 06:16 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 27Buy7.535239211,296,850Oct 01 03:19 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 25Buy7.982,94023,44711,296,798Sep 27 05:08 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 19Buy8.224032911,293,858Sep 21 03:00 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 11Buy8.421714311,465,884Sep 13 04:00 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 06Buy7.844938411,465,867Sep 07 03:21 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorSep 05Buy7.851521,19311,465,818Sep 07 03:21 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 30Buy7.861814111,465,666Sep 04 06:47 PM
Khadder NicholasSee RemarksAug 20Option Exercise0.004,901016,022Aug 22 04:59 PM
McPhail StevenChief Commercial OfficerAug 20Option Exercise0.003,722038,002Aug 22 05:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 20Option Exercise0.005,051020,117Aug 22 05:01 PM
Linthwaite Stephen ChristopherPresident & CEOAug 20Option Exercise0.0012,5620138,433Aug 22 05:00 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 15Buy6.7825,500172,88011,465,648Aug 17 01:23 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 08Buy6.762114211,720,361Aug 10 02:46 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorAug 02Buy6.362918411,720,340Aug 06 03:41 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJul 31Buy6.402,69217,23011,720,311Aug 02 04:05 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJul 27Buy6.1420,029123,07111,717,619Jul 31 03:19 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJul 12Buy6.275433911,697,536Jul 16 02:07 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJul 03Buy6.006136611,697,536Jul 06 03:35 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 22Buy5.453418511,697,475Jul 06 03:35 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 19Buy4.7210,59349,96011,697,441Jun 21 07:31 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 18Buy4.7689,544426,08611,687,194Jun 19 08:50 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 15Buy4.9332,005157,89811,600,578Jun 19 08:50 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 13Buy4.95149,215738,74211,569,391Jun 14 06:28 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 12Buy5.005002,50011,422,857Jun 14 06:28 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 08Buy5.5140,763224,59711,422,357Jun 11 05:41 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJun 07Buy5.5415,00083,03011,381,594Jun 11 05:41 PM
JONES PATRICK SDirectorMay 30Option Exercise0.008,000013,000Jun 01 08:57 PM
BARTHELEMY NICOLASDirectorMay 30Option Exercise0.008,000034,362Jun 01 08:56 PM
Burbach Gerhard FDirectorMay 30Option Exercise0.008,000032,115Jun 01 08:55 PM
COLELLA SAMUEL DDirectorMay 30Option Exercise0.008,000079,923Jun 01 08:55 PM
Paya Carlos VDirectorMay 30Option Exercise0.008,000023,734Jun 01 08:54 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 29Buy5.601,2006,71411,247,392May 31 05:36 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 25Buy5.662,87016,24411,251,041May 29 03:18 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 24Buy5.707,10040,44911,248,171May 29 03:18 PM
McPhail StevenChief Commercial OfficerMay 20Option Exercise0.002,396034,999May 22 09:02 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMay 20Option Exercise0.002,800016,035May 22 09:02 PM
Linthwaite Stephen ChristopherPresident & CEOMay 20Option Exercise0.004,7500122,514May 22 09:02 PM
Khadder NicholasSee RemarksMay 20Option Exercise0.002,650010,978May 22 09:01 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 09Buy5.3716,90090,83611,241,071May 11 05:01 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 08Buy5.4733,000180,43111,226,078May 09 03:56 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 07Buy5.6044,700250,16411,196,801May 09 03:56 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 04Buy5.6889,800510,48211,158,071May 07 05:20 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMay 03Buy5.852,40514,06911,081,432May 07 05:20 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 30Buy5.926,64939,37011,079,027May 02 07:04 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 26Buy5.969,60957,27111,072,378Apr 30 05:15 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 25Buy5.922,40014,20611,062,769Apr 26 04:24 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 24Buy5.951,3007,73311,060,369Apr 26 04:24 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 20Buy5.895002,94711,059,069Apr 24 06:17 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 19Buy5.9210,01359,32511,058,569Apr 24 06:17 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorApr 02Buy5.737,24041,49611,048,556Apr 04 03:57 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 26Buy5.7413,30076,36911,044,231Mar 27 05:20 PM
BARTHELEMY NICOLASDirectorMar 23Option Exercise0.002,500026,362Mar 26 08:57 PM
Paya Carlos VDirectorMar 23Option Exercise0.002,500015,734Mar 26 08:57 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 23Buy5.977,72046,09611,030,931Mar 27 05:20 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 09Buy6.6310770911,023,211Mar 12 06:37 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 08Buy6.4840,000259,11611,023,104Mar 12 06:37 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 05Buy6.177,50046,27310,983,104Mar 06 08:24 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 02Buy6.24248,6551,552,47510,975,756Mar 05 06:20 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorMar 01Buy6.721,70011,42610,733,428Mar 05 06:20 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 28Buy6.808,95060,83310,731,728Mar 01 05:38 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 27Buy6.875,00034,33710,722,778Mar 01 05:38 PM
LEE JENNIFER LINGSee RemarksFeb 20Option Exercise0.001,75507,432Feb 22 04:33 PM
McPhail StevenChief Commercial OfficerFeb 20Option Exercise0.002,397033,450Feb 22 04:32 PM
Khadder NicholasSee RemarksFeb 20Option Exercise0.002,65009,410Feb 22 04:33 PM
Yow Mai ChanSee RemarksFeb 20Option Exercise0.002,279019,705Feb 22 04:32 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 20Option Exercise0.003,034014,474Feb 22 04:32 PM
Linthwaite Stephen ChristopherPresident & CEOFeb 20Option Exercise0.004,7500119,702Feb 22 04:32 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 15Buy7.8610,00078,55810,717,778Feb 20 07:03 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 08Buy5.7412,33870,81810,712,778Feb 12 06:23 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 07Buy5.613,10017,38710,703,370Feb 08 03:02 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 06Buy5.7450,510289,99810,700,270Feb 08 03:02 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 05Buy5.9233,887200,46510,649,760Feb 06 06:47 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 02Buy6.0517,100103,49110,615,873Feb 06 06:47 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorFeb 01Buy6.127,86648,10210,598,773Feb 02 05:32 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 31Buy6.18145,025896,57510,590,907Feb 02 05:32 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 23Buy6.692,99520,02510,445,882Jan 24 05:00 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 22Buy6.483,87625,10110,442,887Jan 24 05:00 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 16Buy6.688875,92810,439,011Jan 18 07:37 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 10Buy6.1435,200215,99810,438,124Jan 11 08:46 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 09Buy6.4565,376421,34810,438,053Jan 11 08:46 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 04Buy6.69138710,379,900Jan 05 03:06 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorJan 03Buy6.632919210,379,887Jan 05 03:06 PM
Paya Carlos VDirectorDec 31Option Exercise0.003,64107,282Jan 03 04:51 PM
COLELLA SAMUEL DDirectorDec 31Option Exercise0.007,848059,093Jan 03 04:52 PM
Burbach Gerhard FDirectorDec 31Option Exercise0.005,259015,518Jan 03 04:52 PM
BARTHELEMY NICOLASDirectorDec 31Option Exercise0.004,611016,323Jan 03 04:52 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 29Buy5.9411,20066,53410,379,858Jan 02 04:47 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 28Buy5.82301751,181,375Jan 02 04:47 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 27Buy5.8521,345124,96610,379,849Dec 28 03:42 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 26Buy6.005,75534,50810,372,892Dec 28 03:42 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 15Buy5.943,79522,53810,367,137Dec 18 06:48 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 14Buy5.8220,380118,52410,363,342Dec 18 06:48 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 12Buy5.8210,83863,09910,342,962Dec 13 07:27 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 11Buy5.867,73145,31010,332,124Dec 13 07:27 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorDec 04Buy5.488,40946,04710,324,393Dec 06 12:45 PM
LEVIN CAPITAL STRATEGIES, L.P.Passive InvestorNov 30Buy5.9576,629455,94310,315,984Dec 04 05:35 PM
open in yahoo | open in reuters | open in google